e-learning
resources
Paris 2018
Monday, 17.09.2018
Lung cancer: new tools for diagnosis and patient assessment
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
An 8 year- review of granulomatous inflammation in EBUS samples- common in sarcoidosis, rare but identified in the setting of cancer where FDG uptake can be observed on PET scanning.
C. Tobin-O'Brien (Dublin, Ireland), S. Skehan (Dublin, Ireland), N. Swan (Dublin, Ireland), M. Mcnally (Dublin, Ireland), M. Butler (Dublin, Ireland), A. Fabre (Dublin, Ireland)
Source:
International Congress 2018 – Lung cancer: new tools for diagnosis and patient assessment
Session:
Lung cancer: new tools for diagnosis and patient assessment
Session type:
Thematic Poster
Number:
2770
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Tobin-O'Brien (Dublin, Ireland), S. Skehan (Dublin, Ireland), N. Swan (Dublin, Ireland), M. Mcnally (Dublin, Ireland), M. Butler (Dublin, Ireland), A. Fabre (Dublin, Ireland). An 8 year- review of granulomatous inflammation in EBUS samples- common in sarcoidosis, rare but identified in the setting of cancer where FDG uptake can be observed on PET scanning.. 2770
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Pulmonary sarcoidosis
Definition and history of sarcoidosis
Related content which might interest you:
Comparison of chest x-ray, thoracic computed tomography and 18F-FDG PET/CT for staging of sarcoidosis
Source: International Congress 2015 – Sarcoidosis: clinical
Year: 2015
Two patients with a nodular lung pattern
Source: Annual Congress 2007 - Radiology Grand Round: an interactive session
Year: 2007
18 F-FDG PET/CT findings mimicking malignant disease in patients with pneumoconiosis (due to 4 cases)
Source: Annual Congress 2009 - Management of thoracic malignancies
Year: 2009
18F-FDG (fluorodeoxyglucose) uptake in focal organizing pneumonia mimicking bronchial carcinoma
Source: Annual Congress 2013 –Diffuse parenchymal lung disease III
Year: 2013
Neurofibromatosis-associated lung disease: a case series and literature review
Source: Eur Respir J 2007; 29: 210-214
Year: 2007
The role of
99m
Tc labelled depreotide scanning in investigating suspected lung cancer - more than just the solitary pulmonary nodule
Source: Eur Respir J 2002; 20: Suppl. 38, 458s
Year: 2002
Management of bone metastases (BM): results of a large multinational, multidisciplinary survey
Source: Annual Congress 2005 - Management of lung cancer: clinical problems
Year: 2005
Pulmonary ANCA-associated vasculitis mimicking a lung tumour or diffuse lung metastases (with positive PET-CT scan)
Source: International Congress 2018 – CC5 Pulmonary vasculitis: the great chameleon
Year: 2018
The role of FDG-PET scanning in the diagnosis of pulmonary nodules suspicious for lung cancer
Source: International Congress 2015 – Advances in pneumonia management, COPD therapy and lung nodule evaluation
Year: 2015
The case of false positive FDG PET/CT scan from foreign body granuloma mimicking malignant disease
Source: Eur Respir J 2006; 28: Suppl. 50, 776s
Year: 2006
CT and FDG PET/CT findings of pulmonary involvement in methotrexate-associated lymphoproliferative disease
Source: International Congress 2018 – CC6 Interstitial lung diseases
Year: 2018
CT safety issues
Source: Research Seminar 2006 - Preventing respiratory sequelae in children diagnosed with cystic fibrosis by newborn screening
Year: 2006
Radiologic and clinical outcomes of small pulmonary nodules detected on low-dose computed tomography
Source: Annual Congress 2005 - Screening and imaging of lung cancer
Year: 2005
Does positron emission tomography (PET/CT) have a role to play in the management of patients presenting with pleural changes suggestive of malignancy
Source: Annual Congress 2009 - Diagnosis and management of pleural effusions and mesothelioma: improving old techniques and new tools
Year: 2009
The usefulness of dynamic CT and
18
F-FDG PET to distinguish between benignancy and malignancy in solitary pulmonary nodule
Source: Eur Respir J 2007; 30: Suppl. 51, 532s
Year: 2007
A lung cancer patient with multiple lesions on PET scan
Source: Annual Congress 2006 - Clinical Grand Round: an interactive session
Year: 2006
The diagnostic value of 18F-FDG PET/CT scanning for discriminating malignant from non-malignant causes in unilateral pleural effusions
Source: International Congress 2018 – Imaging of various diseases with different imaging modalities
Year: 2018
Solitary pulmonary nodules on PET scans – follow up strategy and outcome of low uptake nodules
Source: Eur Respir J 2005; 26: Suppl. 49, 313s
Year: 2005
Scintigraphic imaging (SPECT) with
99m
Tc-depreotide to differentiate benign vs. malignant solitary pulmonary nodules (SPN): results from a multicentre study
Source: Annual Congress 2004 - Recent advances in modern chest imaging and their implications on various clinical problems
Year: 2004
The role of PET-CT in patients undergoing trans bronchial needle aspiration (TBNA) with rapid on-site evaluation (rROSE). Establishing an FDG uptake cutoff
Source: Annual Congress 2007 - Bronchoscopic staging modalities in lung cancer
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept